Lutathera generic availability date?

When will a “generic” Lutathera (lutetium Lu 177 dotatate) be available?

A true generic version of Lutathera depends on when key patent and exclusivity protections end for lutetium Lu 177 dotatate. Patent-driven dates are what most closely determine whether non-brand versions can enter the market.

DrugPatentWatch lists Lutathera’s key patent/exclusivity status and provides the next expected availability timing based on that protection landscape. You can check the most up-to-date “generic availability” date on their page here: https://www.drugpatentwatch.com/p/lutathera/

Is “generic Lutathera” even possible—what about biosimilars?

Lutathera is a radiopharmaceutical (a complex product with radioactive material), so market entry may not look like a standard small-molecule generic. In practice, manufacturers often pursue FDA pathways that fit the product category (and the specific regulatory strategy available at the time), but the earliest timeline still hinges on when exclusivities/patents expire.

What date do people usually mean by “generic availability”?

Searches for “Lutathera generic availability date” typically mean the earliest time a competitor could launch without legal risk from:
- composition-of-matter or related patents, and
- market exclusivity periods (when applicable),
as reflected in drug-patent tracking databases like DrugPatentWatch.

Check the exact date using DrugPatentWatch

For the specific earliest availability date associated with Lutathera protections, use DrugPatentWatch’s maintained record (it’s updated as patent events occur): https://www.drugpatentwatch.com/p/lutathera/

Sources

1. DrugPatentWatch – Lutathera (lutetium Lu 177 dotatate) patent and generic availability timing